NCT05160636View on ClinicalTrials.gov

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

Active, not recruitingOBSERVATIONAL

Enrollment

999

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

COVID-19Coronavirus Disease 2019Influenza

Interventions

BIOLOGICAL

COVID-19 Vaccine

Receipt of Pfizer BioNTech COVID-19 vaccine

Trial Locations (1)

10001

Pfizer, New York

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

CVS Caremark

INDUSTRY

lead

Pfizer

INDUSTRY

NCT05160636 - A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza | Biotech Hunter | Biotech Hunter